Vol. 282, Issue 2, H757-H765, February 2002
Regulation of KATP channels by P2Y
purinoceptors coupled to PIP2 metabolism in guinea pig
ventricular cells
Naoya
Oketani1,
Masafumi
Kakei2,
Kotaro
Ichinari1,
Midori
Okamura1,
Akihiro
Miyamura1,
Mitsuhiro
Nakazaki1,
Seiki
Ito2, and
Chuwa
Tei1
1 First Department of Internal Medicine, Faculty of
Medicine, Kagoshima University, Kagoshima 890-8520; and
2 Division of Geriatric Medicine, Akita University School of
Medicine, Akita 010-8543, Japan
 |
ABSTRACT |
We used patch-clamp techniques to
elucidate the regulatory mechanisms of ATP-sensitive K+
(KATP) channels by stimulation of P2
purinoceptors in guinea pig ventricular myocytes. Extracellular ATP at
0.1 mM transiently inhibited by 90.5 ± 5.0% the whole cell
KATP channel current evoked by a reduction in intracellular
ATP concentration to 0.5 mM and exposure to 30 µM pinacidil. ADP and
AMP (both 1 mM) also decreased the current by 42.8 ± 9.3% and
9.4 ± 4.8%, respectively, but adenosine did not, even at 10 mM.
ATP-induced channel inhibition was hardly observed in the presence of
0.2 mM suramin, 0.2 mM guanosine 5'-O-(2-thiodiphosphate), or 0.1 mM compound 48/80, whereas it was not influenced by the presence
of 0.1 µM staurosporine or 10 mM
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid in
the pipette. In the presence of 10 µM wortmannin or the absence of
ATP in the cytosol, the ATP-induced channel inhibition was
irreversible. Phosphatidylinositol 4,5-bisphosphate (PIP2) at 0.1 mM in the outside-out patch pipette prevented ATP-induced channel inhibition. The half-maximal internal ATP concentrations for
inhibition of channel activity determined in inside-out membrane patches were 13.8 µM in the presence and 1.12 mM in the absence of
0.1 mM ATP at the external side. It is concluded that activity of
KATP channels is modulated by extracellular ATP by a
mechanism involving P2Y purinoceptors coupled to
GTP-binding proteins associated with reduction of the sarcolemmal
PIP2 concentration via stimulation of phospholipase C.
phosphatidylinositol 4,5-bisphosphate, extracellular adenosine
5'-triphosphate; phosphatidylinositol turnover; phospholipase C
 |
INTRODUCTION |
CARDIAC ATP-SENSITIVE
K+ (KATP) channels have been suggested to
play an important role in changes in electrical activity of the
ischemic heart (24, 41). Openings of the channel
reduce the myocardial damage induced by metabolic inhibition as a
consequence of the shortening of action potential duration, which
decreases Ca2+ influx, increases Ca2+ efflux,
and thereby minimizes Ca2+ overload in myocytes. This
concept has been widely accepted as a major pathophysiological
mechanism in KATP channels since its discovery in the heart
(27, 41).
Phosphatidylinositol 4,5-bisphosphate (PIP2) was recently
reported to alter the ATP sensitivity of KATP channels
(1, 10, 15, 30). An increase in PIP2 levels at
the cytoplasmic face of the sarcolemma lowers sensitivity of the
channel to ATP. PIP2 reactivates run-down KATP
channels, which are brought about by exposure to high concentrations of
Ca2+ (39). However, PIP2 did not
reduce ATP sensitivity in KATP channels reactivated by
PIP2 treatment from the run-down state (28).
PIP2 treatment impaired sensitivity of KATP
channels to the sulfonylurea tolbutamide (22). However,
the sustained increase in cytosolic Ca2+ concentration
decreased tolbutamide sensitivity of the channel, whereas
PIP2 and ATP cooperatively protected the channel from the
Ca2+-induced impairment of tolbutamide sensitivity in
pancreatic
-cells (21). These findings suggest that
membrane PIP2 is a maintenance modulator of channel
activity and sensitivity to sulfonylureas as well as ATP.
ATP acts as an extracellular signal in various types of tissues
involved regulation of vascular tone, muscle contraction, pain, or
neuronal communication (6). Under hypoxic or
ischemic conditions, the source of extracellular ATP is
reportedly parenchymal cells (31). Many biological
responses to ATP are mediated via the P2 purinoceptor
family, which are classified into two structurally and functionally
distinct group of receptors: ligand-gated nonselective cation channels
(P2X-type receptors) and GTP-binding protein (G protein)-coupled receptors linked to the phospholipase C (PLC) signaling cascade (P2Y-type receptors; Refs. 5
and 6). Binding of extracellular ATP to P2Y purinoceptors
stimulates PLC to cleave PIP2 into diacylglycerol (DG) and
inositol 1,4,5-trisphosphate (IP3) (2). We
therefore postulated that stimulation of these pathways may change the
activity of KATP channels by altering the sarcolemmal
PIP2 concentration. In the present study, we attempted to
clarify whether extracellular ATP modulates activity of the KATP channels, and the underlying mechanisms were explored
in ventricular myocytes isolated from guinea pig hearts.
 |
METHODS |
Studies were performed in single ventricular myocytes
enzymatically isolated from guinea pig hearts as described previously (34). Briefly, male guinea pigs weighing 210-300 g
were anesthetized with pentobarbital sodium (26 mg/kg) by peritoneal
injection and were artificially ventilated. After thoracotomy, the
heart was cannulated into the aorta, quickly excised, mounted on a
Langendorff apparatus, and perfused at 37°C with oxygenated Tyrode
solution containing (in mM) 137 NaCl, 5.4 KCl, 1.8 CaCl2,
1.5 MgCl2, 0.33 NaH2PO4, and 5.5 glucose (pH 7.4 with NaOH). The perfusate was switched to a nominally
Ca2+-free oxygenated Tyrode solution (100 ml), and
Ca2+-free Tyrode solution containing 0.04% collagenase
(Worthington type II) was perfused for 15 min. The heart was then
perfused to wash out collagenase with 100 ml of Kraftbrühe (KB)
solution (18) containing (in mM) 40 KCl, 20 taurine, 50 glutamic acid, 20 KH2PO4, 3 MgCl2,
10 glucose, 0.5 EGTA, and 10 HEPES (pH 7.4 with KOH). The left
ventricle was removed and cut into small pieces (~5 mm3)
in KB solution and dispersed mechanically into single cells. The
dispersed myocytes were stored in KB solution at 4°C for at least
1 h before use. Single ventricular myocytes were then placed in a
recording chamber (500 µl), which was filled with Tyrode solution.
Experiments were started after the cells had settled to the bottom
of the chamber.
Patch pipettes were pulled from hard glass tubing (Sutter Instrument,
Novato, CA), coated with silicon resin to reduce electrical capacitance, and fire polished immediately before use. Pipette resistances were between 2 and 3 M
for whole cell experiments and
were ~5-10 M
for experiments of outside-out or inside-out membrane patches. All experiments were performed at 23-26°C.
Whole cell and single KATP channel currents were recorded
from ventricular myocytes with the conventional patch-clamp technique (12). Data were recorded with an amplifier (Axopatch 200B,
Axon Instruments, Foster City, CA) and stored by means of a PCM digital data recorder (RD-101T; TEAC, Tokyo, Japan). Replayed recordings were
then low-pass filtered (24 dB/octave, E-3211A; NF, Tokyo, Japan) at the
cut-off frequency indicated in Figs. 1, 4, 5, and 7 and digitized by
pCLAMP6 or -7 software (Axon Instruments) on an IBM computer.
In some experiments, on-line recordings of the whole cell current were
performed.

View larger version (26K):
[in this window]
[in a new window]
|
Fig. 1.
Effect of extracellular ATP on ATP-sensitive K+
(KATP) channel currents. A: chart recordings of
the KATP channel current at the beginning of whole cell
recording during voltage ramps (a). Decreasing the
cytoplasmic ATP concentration through the pipette solution containing
the lower ATP concentration (0.5 mM) and exposure of the cell to 30 µM pinacidil caused gradual increases in the outward current. In
current tracings at point b the maximal current level
reached several nanoamperes as illustrated in B. The top of
the current tracings was cut in the chart recorder. ATP transiently
inhibited KATP channel currents with minimal levels
(c). The current was inhibited by 10 µM glibenclamide
(d). Data were filtered at the cut-off frequency of 800 Hz.
B: current-voltage relations for KATP channel currents
(a to d) recorded at the times indicated in
A are illustrated. C: the subtracted
current-voltage relations of b d and
b c are illustrated. D:
concentration-response relations of %inhibition of the amplitudes of
the KATP channel currents at +20 mV for extracellular ATP.
Values are means ± SE of 3-10 results.
|
|
The ventricular myocytes were voltage-clamped at the holding potential
of
70 mV, and voltage ramps were applied every 5 or 10 s from
100 mV to +50 mV at 75 mV/s and, subsequently, ramps to
70 mV at
120 mV/s. The current-voltage relations were calculated from the
measurements at the down slope of the voltage ramps. To compare the
effects of extracellular nucleotides or chemicals on the activity of
KATP channels, amplitudes of KATP channel
currents were measured at +20 mV. The percent inhibition of the channel current was obtained from the following equation (see Fig.
1): %inhibition = 100(Imax
Itest)/(Imax
Iglib), where Imax is the
current amplitude maximally activated by reduction in the ATP
concentration in the pipette to 0.5 mM and exposure to 30 µM
pinacidil, a KATP channel opener;
Itest is current amplitude during exposure to
test solutions; and Iglib is current amplitude during exposure to 10 µM glibenclamide. The concentration-response relations of KATP channel currents for ATP concentrations
were fitted by the Hill equation: %inhibition = 100/[1 + (IC50/[ATP])nH],
where IC50 is the concentration for half-maximal channel
inhibition, [ATP] is ATP concentration, and nH
is the Hill coefficient.
Pipette solutions contained (in mM) 50 KCl, 90 aspartic acid, 1 KH2PO4, 1 MgCl2, 5 HEPES, 5 EGTA,
0.5 Na2ATP, and 0.1 GTP (pH adjusted to 7.2 with KOH).
Na2ATP, Na2ADP, and adenosine were obtained
from Boehringer (Mannheim, Germany). Na2GTP, suramin, and
wortmannin were obtained from Nacalai (Kyoto, Japan). Compound 48/80
was obtained from Biomol (Plymouth Meeting, PA). Glibenclamide, staurosporine, pinacidil, and
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid
(BAPTA) were purchased from Sigma (St. Louis, MO). Glibenclamide was
dissolved in DMSO to be stocked and used at the indicated concentration. PIP2 was dissolved in 0.1% DMSO and diluted
by the pipette solution by sonication on ice for 30 min.
Values are expressed as means ± SE. Student's unpaired
t-test or one-way ANOVA test was used to evaluate the
difference between groups using Prism software (GraphPad Software). The
time constants were obtained by fitting the data to a single
exponential function with Prism software.
 |
RESULTS |
Inhibition of KATP channel currents by extracellular
ATP.
Because KATP channels are known to be independent of
membrane voltage (19), the voltage ramp protocol was used
to obtain current-voltage relations of KATP channels. The
membrane potential was stepped to
100 mV from the holding potential
of
70 mV, and voltage ramps to +50 mV and then to
70 mV were
applied to evoke currents. The corresponding current traces are
illustrated in Fig. 1A. The large inward current and small
outward current through the inwardly rectifying K+ channel
current (IK1) with a negative slope conductance
were recorded at point a as shown in Fig. 1, A
and B. In Fig. 1A, a gradual increase in the
outward current was observed with a reduction in cytosolic ATP
concentration by dialysis through the pipette solution containing 0.5 mM ATP and exposure to 30 µM pinacidil (Fig. 1A, point b).
The inward current was also reduced before the increase in the outward
current because amplitudes of mean IK1 have been
reported to be inhibited by decreasing intracellular ATP concentration
(19) and subsequently appeared to be increased in
association with the increase in the outward current at point b. This small increase in the inward current may reflect
activation of KATP channels. After exposure to 0.1 mM ATP,
both the outward and inward currents were transiently reduced
(point c). Glibenclamide, a specific blocker of
KATP channels, substantially inhibited these currents at 10 µM (point d). This suggested that the current increased during the reduction in the cytosolic ATP concentration and inhibited by exposure to extracellular ATP must be that via the KATP
channels (11). In Fig. 1B, the current-voltage
relations obtained at the time indicated in Fig. 1A were
plotted. The current-voltage relations (point a) showed a
negative slope conductance with a small current level at the positive
membrane potentials. These are properties of IK1
currents. The large increase in the outward current in association with
the reduction in the cytoplasmic ATP levels was characterized by the
increase in the current level at positive potentials with a reduced
negative slope (point b). At points c
and d, current-voltage relations similar to those at
point a were depicted during superfusion with 0.1 mM ATP or 10 µM glibenclamide. The current-voltage relations of d
subtracted from b indicated the glibenclamide-sensitive
component and the difference between b and c was
the extracellular ATP-inhibited currents (Fig. 1C). Because
both curves showed similar relations against membrane potentials with
the same reversal potential and a weak inwardly rectifying property,
the current inhibited by ATP was that via the KATP channels
(19). In Fig. 1D, concentration-response relations of the KATP channel currents for extracellular
ATP measured at +20 mV are plotted. IC50 was calculated to
be 4.2 µM.
Comparison of relative inhibitory potency of nucleotides and
nucleosides on KATP channel currents.
Both P1 and P2 purinoceptors were found in
guinea pig atrial and ventricular myocytes (7, 8, 25, 38).
Various types of nucleotides were used to test the inhibitory efficacy
on the KATP channel currents elicited by exposure to 30 µM pinacidil and 0.5 mM ATP in the pipette (Fig.
2). The magnitude of the activated KATP channel current and the degree of inhibition of the
negative slope were variable from cell to cell. This may have been
caused by differences in cell size and in the capability of diffusion of intracellular ATP through the whole cell pipettes. Thus amplitudes of KATP channel currents were measured at +20 mV, and the
percent inhibition of the current by nucleotides compared with controls are illustrated in Fig. 2D. The effectiveness of ADP and AMP
on channel inhibition was less than that of ATP. ADP at 1 mM reduced the channel current by 42.8 ± 9.3% and 1 mM AMP reduced the
current by 9.4 ± 4.8% (Fig. 2, A, B, and
D). Adenosine had little effect on KATP channel
currents, even at 10 mM (Fig. 2, C and D).
P2 purinoceptors have been classified into two structurally
and functionally distinct families, the P2X and
P2Y types. Exposure of cells to 0.1 mM
,
-methylene
ATP, a P2X-selective agonist, caused only a small reduction
in the KATP channel currents with an inhibition of
28.3 ± 121% (n = 5). The order of the inhibitory
efficacy on the activity of the KATP channels was therefore
ATP >
,
-methylene ATP = ADP > AMP > adenosine.

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 2.
Effects of various types of nucleotides and nucleosides on
current-voltage relations of the KATP channel current
evoked by a reduction in ATP in the pipette. The current-voltage
relations in the absence (control) and presence of 1 mM ADP
(A), 1 mM AMP (B), and 10 mM adenosine
(C) are illustrated. In each trace, 10 µM glibenclamide
was added at the end of the recordings to find the
glibenclamide-sensitive amplitudes of KATP channel
currents. D: %inhibition during exposure to each test
solution measured at +20 mV and plotted. The 1-way ANOVA test was used
to evaluate the difference between groups. (*P < 0.05;
**P < 0.01).  mATP, , -methylene ATP.
|
|
Signaling pathway for channel inhibition by ATP.
Binding of extracellular ATP to P2Y purinoceptors coupled
to G protein has been reported to stimulate PLC to cleave
PIP2 into DG and IP3 (2). We
tested the effects of ATP in the presence of 0.2 mM suramin, which
binds to P2 purinoceptors competitively with ATP
(17). Suramin prevented ATP-induced channel inhibition, and the inhibition of the channel current was reduced to 14.6 ± 4.5% (n = 5; Fig. 3).
Involvement of G proteins or PLC in ATP-induced KATP
channel inhibition was also tested with a pipette solution containing
guanosine 5'-O-(2-thiodiphosphate) (GDP
S; 0.2 mM), a
nonhydrolyzable GDP analog (16), or compound 48/80, a PLC inhibitor (4). The inhibition of the channel current by
ATP was reduced to 31.3 ± 9.9% (n = 5) by
GDP
S and to 15.9 ± 6.4% (n = 6) by compound
48/80. These findings suggested that extracellular ATP inhibited the
activity of the KATP channels via the pathway including
P2Y purinoceptor, G protein, and PLC.

View larger version (11K):
[in this window]
[in a new window]
|
Fig. 3.
Effects of various types of compounds, inhibitors, or
chelators of key elements in the subcellular pathway from
P2Y purinoceptors on 0.1 mM ATP-induced KATP
channel inhibition. The 1-way ANOVA test was used to evaluate the
difference between groups. (**P < 0.01 vs. 0.1 mM
ATP). GDP S, guanosine 5'-O-(2-thiodiphosphate); BAPTA,
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid.
|
|
Effects of factors distal to PLC on KATP channels.
Stimulation of P2Y purinoceptors causes cleavage of
PIP2 to DG and IP3. These metabolites
consequently activate protein kinase (PKC) and increase the cytosolic
Ca2+ concentration (2, 6). Staurosporine is
known to block the activity of PKC by direct interaction
(33). In the presence of 0.1 µM staurosporine,
KATP channel currents were inhibited by 0.1 mM ATP to an
extent similar to the controls. Likewise, when 10 mM BAPTA, a potent
Ca2+ chelator, was substituted for EGTA in the pipette
solution, the inhibitory efficacy of the channels by ATP did not
change. The inhibition by ATP was 79.1 ± 12.9% with
staurosporine (n = 5) and 91.2 ± 6.3% with BAPTA
(n = 5). These findings suggest that neither PKC nor
change in cytosolic Ca2+ concentration was involved in
ATP-induced KATP channel inhibition.
Effects of wortmannin or PIP2 on ATP-induced inhibition
of KATP channel currents.
From the findings presented above, we postulated an involvement of
change in PIP2 concentration via modification of lipid metabolism in the sarcolemma on ATP-induced KATP channel
inhibition. Because PIP2 is a determinant of the basal
activity of KATP channels in ATP-free solution (28,
39), the reduction in the PIP2 concentration in the
sarcolemma by P2Y purinoceptor stimulation may consequently decrease the activity of the KATP channels. Wortmannin, an
inhibitor of phosphatidylinositol 3-kinase and -4-kinase, inhibits
conversion to phosphatidylinositol 3,4,5-trisphosphate
(PIP3) from PIP2 by lipid phosphorylation and
the replenishment of PIP2 (37). In the
presence of 10 µM wortmannin, ATP-induced inhibition of
KATP channel currents was irreversible (n = 4; Fig. 4A). Because
production of PIP2 is regulated by activity of lipid
kinases sensitive to wortmannin, inhibition of these enzymes by
wortmannin may be expected to reduce the supply of PIP2 in
the sarcolemma. Under these conditions, stimulation of PLC by
extracellular ATP may reduce the levels of PIP2 in the
sarcolemma. Similarly, the reduction of PIP2 in the
sarcolemma by stimulation of P2Y purinoceptors may have
been exaggerated when cytosolic ATP levels were reduced with the
pipette solution containing 0 mM ATP. The activity of the
KATP channels was irreversibly inhibited by 0.1 mM ATP in
the absence of intracellular ATP in outside-out membrane patches
(n = 6; Fig. 4B). With 0.1 mM
PIP2 in the pipette solution, the KATP channel
currents were not inhibited by 0.1 mM ATP in any of the membrane
patches tested (n = 5; Fig. 4C).

View larger version (34K):
[in this window]
[in a new window]
|
Fig. 4.
Involvement of phosphatidylinositol 4,5-bisphosphate
(PIP2) metabolism in ATP-induced KATP channel
current inhibition. A: the whole cell KATP
channel current was evoked by 30 µM pinacidil (arrow) with the
pipette solution containing 0.5 mM ATP. ATP at 0.1 mM and 10 µM
wortmannin was superfused during the period shown above the trace. The
inhibition of the KATP channel currents was irreversible
even after the washout of ATP and wortmannin. B: a single
KATP channel current evoked by depleting intracellular ATP
to 0 mM in the outside-out mode is illustrated. The channel inhibition
by 0.1 mM ATP was also irreversible. C: outside-out patch
recordings for KATP channels with the pipette solution
containing 0.1 mM PIP2 are illustrated. ATP at 0.1 mM did
not inhibit channel activity, but 10 µM glibenclamide did. The patch
membrane potential was clamped at +20 mV in B and
C, and data were filtered at the cut-off frequency of 800 Hz.
|
|
Enhanced sensitivity of KATP channels to cytosolic ATP
in presence of extracellular ATP.
We examined the effects of extracellular ATP on the
concentration-response relations of the KATP channel
currents for ATP at the cytosolic side in inside-out membrane patches
(Fig. 5). The presence of 0.1 mM ATP at
the extracellular side of the membrane patches rapidly reduced
KATP channel activity after formation of the inside-out
mode. Thus we superfused 30 µM pinacidil to increase the channel
current to detect concentration-dependent channel inhibition by ATP
throughout the experiments (Fig. 5, A and B). The
IC50 for the channel inhibition by ATP was shifted from
1.12 mM in the controls to 13.8 µM in the presence of 100 µM ATP in
the pipette. Thus the reduction of PIP2 levels in membrane patches may be brought about by stimulation of P2Y
purinoceptors by ATP and may increase the ATP sensitivity of the
channels. This may be the underlying mechanism of P2Y
purinoceptor-stimulated KATP channel inhibition. These
findings were comparable to those previously reported in cells
expressed with both P2Y purinoceptors or muscarinic
receptors and KATP channels (1, 40).

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 5.
Shift of ATP sensitivity of KATP channels in the
presence of 100 µM ATP at the outside of the membrane patches.
A and B: the KATP channel currents were recorded
in the absence (A) and presence (B) of 0.1 mM ATP
in the pipette in inside-out membrane patches. The membrane excised
from the cells was exposed to 30 µM pinacidil to evoke the channel
current because channel currents would otherwise be inhibited by
extracellular ATP even in the absence of intracellular ATP. The current
data were filtered at 800 Hz. The baseline levels are indicated with
short bars (designated 0) beside current traces. C: the
concentration-response relations of KATP channel activity
for ATP concentrations are illustrated. The KATP channel
currents were recorded at a patch membrane potential of 60 mV with
various concentrations of ATP in the internal solution, and the
relative current, normalized to the current obtained in the absence of
ATP, is plotted with pipette solution containing 100 µM ATP
( ) or without ATP ( ). The curves were
drawn according to the following equation: relative current = 1/[1 + ([ATP]/IC50)nH],
where IC50 is concentration for half-maximal channel
inhibition, [ATP] is ATP concentration, and nH
is the Hill coefficient.
|
|
ATP-induced inhibition of KATP channel currents is
dependent on cytosolic ATP concentration.
In Fig. 6, intracellular ATP dependence
of extracellular ATP-induced KATP channel inhibition is
shown. Extracellular ATP at 0.1 mM inhibited whole cell
KATP channel currents that were evoked by 30 µM pinacidil
in the presence of 3 mM ATP in the pipette. The inhibitory efficacy was
35.5 ± 10.0% (n = 7), and this was less than
that in the presence of 0.5 mM ATP in the pipette solution (Fig.
6B; P < 0.01). ATP-induced channel
inhibition was transient as illustrated in Fig. 1A. Figure
6C shows the time course of relative amplitudes of
KATP channel currents in response to extracellular ATP in
the presence of intracellular ATP of 3 or 0.5 mM. The time to maximal
inhibition of the KATP channel current was 245.0 ± 110.0 s in the presence of 3 mM ATP (n = 7) in the
pipette and 819 ± 30.0 s at 0.5 mM ATP (n = 8; P = 0.12). The time constants for the inhibitory
phase of the KATP channel amplitude were 80.1 ± 29.6 s in the presence of 0.5 mM ATP (n = 3) in
the pipette and 371.4 ± 101.8 s in the presence of 3 mM ATP
(n = 4; P < 0.05). In the presence of
guanosine 5'-O-(3-thiotriphosphate) (GTP
S; 0.2 mM), a
nonhydrolyzable GTP analog, in the pipette solution, ATP-induced
KATP channel inhibition was irreversible despite the presence of 0.5 mM ATP at the cytosol (Fig.
7).

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 6.
Dependence of ATP-induced KATP channel inhibition on
intracellular ATP. A: current-voltage relations obtained in
the presence of intracellular 3 mM ATP are illustrated in the absence
(control) and presence of extracellular 0.1 mM ATP. To determine the
amplitudes of the channel currents sensitive to glibenclamide, 10 µM
glibenclamide was added at the end of the experiments. B:
comparison between the findings obtained with 0.5 mM ATP and 3 mM ATP
in the pipette. The currents were measured at +20 mV, and the
%inhibition was plotted (Student's unpaired t-test;
**P < 0.01). C: time course of the
relative amplitude of KATP channel currents during exposure
to extracellular 0.1 mM ATP plotted in the presence of 3 mM and 0.5 mM
ATP in the pipette. Data were normalized to the amplitudes of
KATP channel currents immediately before exposure to
extracellular 0.1 mM ATP.
|
|

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 7.
Irreversible inhibition of KATP channel current by 0.1 mM ATP in the presence of 0.2 mM guanosine
5'-O-(3-thiotriphosphate) (GTP S) in the pipette.
KATP channel currents were evoked by depletion of the
intracellular ATP concentration to 0.5 mM and exposure to 30 µM
pinacidil as indicated by an increase in the outward current
amplitudes. Data were filtered at the cut-off frequency of 800 Hz.
|
|
 |
DISCUSSION |
In the present study, we demonstrated that extracellular ATP
reduced KATP channel currents because of the binding of ATP
to purinoceptors. These findings revealed a significantly stronger inhibitory efficacy with ATP than with
,
-methylene ATP, and the
order for blocking effectiveness, ATP >
,
-methylene ATP = ADP > AMP > adenosine, suggested that ATP-induced
KATP channel inhibition was mediated by P2Y
purinoceptors. Cardiac myocytes express different types of ATP
receptors that consist of ligand-gated ion channels (P2X
type) and that couple to PLC via heterotrimeric G proteins
(P2Y type) (9). The present observations that
extracellular ATP-induced KATP channel inhibition involved
receptor-mediated stimulation of PLC coupled to G proteins support the
idea that P2Y-type receptors are expressed in guinea pig
ventricular myocytes and physiologically regulate KATP
channels. Although KATP channel inhibition mediated by
either P2Y purinoceptors or muscarinic receptors has been
reported in cells overexpressed with KATP channels and
PLC-linked receptors (1, 40), the present findings provide evidence that the breakdown of PIP2 mediates the activity
of the KATP channels via PLC-linked receptors under
physiological conditions.
In inside-out membrane patches, PIP2 is reportedly a
regulator of KATP channels (1, 10, 15, 30). In
the present study, we observed that the presence of extracellular ATP
in inside-out membrane patches shifted the IC50 toward
lower concentrations of ATP (Fig. 5). This suggests that the decrease
in PIP2 levels in the membrane increases the sensitivity of
the KATP channels to intracellular ATP and thereby reduces
the activity of the channels. Ca2+ treatment of membrane
patches attenuated the activity of the KATP channels
(rundown of the channels), and subsequent treatment with
PIP2 restored channel activity (28, 39).
Rundown of KATP channel activity observed during
Ca2+ treatment (28, 39) or in ATP-free
solution (28) may reflect depletion of PIP2
levels in the membrane. However, the rundown of channel activity may
not be simply due to depletion of PIP2 in the membrane
because channel activity restored from the run-down state by
PIP2 treatment did not exhibit less ATP sensitivity
(28). Thus a more complicated mechanism regarding
modulation of the channel gating by PIP2 may be required.
PKC or Ca2+ mobilization from the intracellular store sites
may not be involved in KATP channel inhibition by ATP (Fig.
3). We observed irreversible channel inhibition in the presence of wortmannin or the absence of intracellular ATP, whereas staurosporine or BAPTA did not influence extracellular ATP-induced KATP
channel inhibition (Fig. 4, A and B). The levels
of PIP2 in the sarcolemma appeared to be regulated by a
balance of replenishment from ATP via wortmannin-sensitive lipid
kinases (37), expenditure via stimulation of PLC, and
dephosphorylation by intrinsic phosphatase activity. Thus the reduction
of sarcolemmal PIP2 levels by means of stimulation of
P2Y purinoceptors may be a final determinant for the
inhibition of activity of KATP channels. This was supported by the observation that ATP-induced channel inhibition was prevented when 0.1 mM PIP2 was present in the outside-out pipette
solution. However, the possible involvement of PIP3, which
may be a main mediator of KATP channels rather than
PIP2 in diabetic ob/ob mice (23) or the
insulinoma cell line (13), is not excluded. We did not
find whole cell KATP channel current activation with
PIP2 in the pipette up to 1 mM. This may be due to the
following reasons. Diffusion of PIP2 through the pipette
may not be adequate to activate KATP channels, which has
been reported to take several hours (1), and the majority
of PIP2 may be absorbed into the glass wall of the pipette
(14). Likewise, injected PIP2 may be
dephosphorylated by intrinsic phosphatase activity.
Extracellular ATP-induced inhibition of the KATP channels
was transient (Figs. 1A and 6C) and was dependent
on the concentration of ATP at the cytoplasmic side (Fig.
6B). Because ATP is a phosphate donor for lipid kinase,
increased ATP levels in the cytosol may result in greater production of
PIP2 levels in the sarcolemma. Observations that both the
magnitude of the reduction and the inhibitory time constant of
KATP channel currents on simulation of P2Y
purinoceptors were dependent on the cytosolic ATP concentration may
suggest that cytoplasmic levels of ATP underneath the sarcolemma may
also influence the rate of the reduction of PIP2 levels in the sarcolemma. The finding that persistent inhibition of the channel
currents was observed in the presence of GTP
S in the cytosol (Fig.
7) suggests that desensitization of the extracellular ATP-induced
reduction of KATP channel currents occurred at a site proximal to stimulation of PLC. In a recent study a new insight that
hydrolysis of PIP2 by PLC in the membrane accounts for a new form of desensitization in the GTP-binding protein-gated inwardly rectifying potassium channel current stimulated by acetylcholine has
been demonstrated in atrial cells (20).
Takizawa et al. (32) reported that the whole cell
KATP channel current was inhibited by norepinephrine. We
also found that norepinephrine at a concentration of 0.1 µM inhibited
the KATP channels (data not shown). Thus a similar
mechanism may be involved in norepinephrine-induced KATP
channel inhibition because
1-adrenoceptors stimulate
phosphatidylinositol metabolism (3, 35). The
IC50 for ATP-induced KATP channel inhibition
was 4.8 µM, which may be a physiologically relevant concentration at
the extracellular space. Similar effective concentrations for
extracellular ATP-induced modulation of ionic channels have been
reported for the delayed-rectifier K+ current in the guinea
pig heart (26) and for the Ca2+ channel
current in the ferret heart (29) via P2Y
purinoceptors. In the normal heart, the interstitial ATP concentration
is reportedly in the nanomolar range (31), but it may be
increased to micromolar levels in the ischemic heart
(36). However, the overall effects of extracellular ATP on
cardiac cells during ischemia remain to be determined.
 |
ACKNOWLEDGEMENTS |
This work was supported in part by a Grant-in-Aid for Scientific
Research (C) from the Japan Society for the Promotion of Science (to M. Kakei).
 |
FOOTNOTES |
Address for reprint requests and other correspondence: N. Oketani, First Dept. of Internal Medicine, Faculty of Medicine, Kagoshima Univ., 8-35-1 Sakuragaoka, Kagoshima 890-8520, Japan (E-mail:
oketani{at}m.kufm.kagoshima-u.ac.jp).
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement"
in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
10.1152/ajpheart.00246.2001
Received 26 March 2001; accepted in final form 19 October 2001.
 |
REFERENCES |
1.
Baukrowitz, T,
Schulte U,
Oliver D,
Herlitze S,
Krauter T,
Tucker SJ,
Ruppersberg JP,
and
Fakler B.
PIP2 and PIP as determinants for ATP inhibition of KATP channels.
Science
282:
1141-1144,
1998.
2.
Berridge, MJ,
and
Irvine RF.
Inositol trisphosphate, a novel second messenger in cellular signal transduction.
Nature
312:
315-322,
1984.
3.
Billah, MM,
and
Michell RH.
Phosphatidylinositol metabolism in rat hepatocytes stimulated by glycogenolytic hormones. Effects of angiotensin, vasopressin, adrenaline, ionophore A24187 and calcium-ion deprivation.
Biochem J
182:
661-668,
1979.
4.
Bronner, C,
Wiggins C,
Monte D,
Marki F,
Capron A,
Landry Y,
and
Franson RC.
Compound 48/80 is a potent inhibitor of phospholipase C and a dual modulator of phospholipase A2 from human platelet.
Biochim Biophys Acta
920:
301-305,
1987.
5.
Burnstock, G.
P2 purinoceptors: historical perspective and classification.
Ciba Found Symp
198:
1-34,
1996.
6.
Burnstock, G.
The past, present and future of purine nucleotides as signaling molecules.
Neuropharmacology
36:
1127-1139,
1997.
7.
Burnstock, G,
and
Meghji P.
Distribution of P1- and P2-purinoceptors in the guinea-pig and frog heart.
Br J Pharmacol
73:
879-885,
1981.
8.
Dorigo, PR,
Gaion M,
and
Maragno I.
Negative and positive influences exerted by purine compounds on isolated guinea-pig atria.
J Auton Pharmacol
8:
191-196,
1988.
9.
Dubyak, GR,
and
el-Moatassim C.
Signal transduction via P2-purinergic receptors for extracellular ATP and other nucleotides.
Am J Physiol Cell Physiol
265:
C577-C606,
1993.
10.
Fan, Z,
and
Makielski JC.
Anionic phospholipids activate ATP-sensitive potassium channels.
J Biol Chem
272:
5388-5395,
1997.
11.
Fosset, M,
De Weille JR,
Green RD,
Schmid-Antomarchi H,
and
Lazdunski M.
Antidiabetic sulfonylureas control action potential properties in heart cells via high affinity receptors that are linked to ATP-dependent K+ channels.
J Biol Chem
263:
7933-7936,
1988.
12.
Hamill, OP,
Marty A,
Neher E,
Sakmann B,
and
Sigworth FJ.
Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches.
Pflügers Arch
391:
85-100,
1981.
13.
Harvey, J,
McKay NG,
Walker KS,
Van der Kaay J,
Downes CP,
and
Ashford ML.
Essential role of phosphoinositide 3-kinase in leptin-induced KATP channel activation in the rat CRI-G1 insulinoma cell line.
J Biol Chem
275:
4660-4669,
2000.
14.
Hilgemann, DW.
The giant membrane patch.
In: Single Channel Recording, edited by Sakmann B,
and Neher E.. New York: Plenum, 1995, p. 307-327.
15.
Hilgemann, DW,
and
Ball R.
Regulation of cardiac Na+, Ca2+ exchange and KATP potassium channels by PIP2.
Science
273:
956-959,
1996.
16.
Holz, GG, IV,
Rane SG,
and
Dunlap K.
GTP-binding proteins mediate transmitter inhibition of voltage-dependent calcium channels.
Nature
319:
670-672,
1986.
17.
Hoyle, CH,
Knight GE,
and
Burnstock G.
Suramin antagonises responses to P2-purinoceptor agonists and purinergic nerve stimulation in the guinea-pig urinary bladder and taenia coli.
Br J Pharmacol
99:
617-621,
1990.
18.
Isenberg, G,
and
Klöckner U.
Calcium tolerant ventricular myocytes prepared by preincubation in a "KB medium".
Pflügers Arch
395:
6-18,
1982.
19.
Kakei, M,
Noma A,
and
Shibasaki T.
Properties of adenosine-triphosphate-regulated potassium channels in guinea-pig ventricular cells.
J Physiol (Lond)
363:
441-462,
1985.
20.
Kobrinsky, E,
Mirshahi T,
Zhang H,
Jin T,
and
Logothetis DE.
Receptor-mediated hydrolysis of plasma membrane messenger PIP2 leads to K+-current desensitization.
Nat Cell Biol
2:
507-514,
2000.
21.
Koriyama, N,
Kakei M,
Nakazaki M,
Yaekura K,
Ichinari K,
Gong Q,
Morimitsu S,
Yada T,
and
Tei C.
PIP2 and ATP cooperatively prevent cytosolic Ca2+-induced modification of ATP-sensitive K+ channels in rat pancreatic
-cells.
Diabetes
49:
1830-1839,
2000.
22.
Koster, JC,
Sha Q,
and
Nichols CG.
Sulfonylurea and K+-channel opener sensitivity of KATP channels, functional coupling of Kir6.2 and SUR1 subunits.
J Gen Physiol
114:
203-213,
1999.
23.
Larsson, O,
Barker CJ,
and
Berggren PO.
Phosphatidylinositol 4,5-bisphosphate and ATP-sensitive potassium channel regulation: a word of caution.
Diabetes
49:
1409-1412,
2000.
24.
Li, RA,
Leppo M,
Miki T,
Seino S,
and
Marban E.
Molecular basis of electrocardiographic ST-segment elevation.
Circ Res
87:
837-839,
2000.
25.
Mantelli, L,
Amerini S,
Filippi S,
and
Ledda F.
Blockade of adenosine receptors unmasks a stimulatory effect of ATP on cardiac contractility.
Br J Pharmacol
109:
1268-1271,
1993.
26.
Matsubayashi, T,
Matsuura H,
and
Ehara T.
On the mechanism of the enhancement of delayed rectifier K+ current by extracellular ATP in guinea-pig ventricular myocytes.
Pflügers Arch
437:
635-642,
1999.
27.
Noma, A.
ATP-regulated K+ channels in cardiac muscle.
Nature
305:
147-148,
1983.
28.
Okamura, M,
Kakei M,
Ichinari K,
Miyamura A,
Oketani N,
Koriyama N,
and
Tei C.
State-dependent modification of ATP-sensitive K+ channels by phosphatidylinositol 4,5-bisphosphate.
Am J Physiol Cell Physiol
280:
C303-C308,
2001.
29.
Qu, Y,
Campbell DL,
and
Strauss HC.
Modulation of L-type Ca2+ current by extracellular ATP in ferret isolated right ventricular myocytes.
J Physiol (Lond)
471:
295-317,
1993.
30.
Shyng, SL,
and
Nichols CG.
Membrane phospholipid control of nucleotide sensitivity of KATP channels.
Science
282:
1138-1141,
1998.
31.
Skobel, E,
and
Kammermeier H.
Relation between enzyme release and irreversible cell injury of the heart under the influence of cytoskeleton modulating agents.
Biochim Biophys Acta
1362:
128-134,
1997.
32.
Takizawa, T,
Hara Y,
Saito T,
Masuda Y,
and
Nakaya H.
Alpha1-adrenoceptor stimulation partially inhibits ATP-sensitive K+ current in guinea pig ventricular cells: attenuation of the action potential shortening induced by hypoxia and K+ channel openers.
J Cardiovasc Pharmacol
28:
799-808,
1996.
33.
Tamaoki, T,
Nomoto H,
Takahashi I,
Kato Y,
Morimoto M,
and
Tomita F.
Staurosporine, a potent inhibitor of phospholipid/Ca++ dependent protein kinase.
Biochem Biophys Res Commun
135:
397-402,
1986.
34.
Taniguchi, J,
Kokubun S,
Noma A,
and
Irisawa H.
Spontaneously active cells isolated from the sino-atrial and atrio-ventricular nodes of the rabbit heart.
Jpn J Physiol
31:
547-558,
1981.
35.
Tolbert, ME,
White AC,
Aspry K,
Cutts J,
and
Fain JN.
Stimulation by vasopressin and
-catecholamines of phosphatidylinositol formation in isolated rat liver parenchymal cells.
J Biol Chem
255:
1938-1944,
1980.
36.
Vassort, G,
Puceat M,
and
Alvarez J.
Regulation of cardiac activity by ATP, a purine agonist.
In: Molecular Physiology and Pharmacology of Cardiac Ion Channels and Transporters, edited by Morad M,
Ebashi S,
Trautwein W,
and Kurachi Y.. Dordrecht, The Netherlands: Kluwer, 1996, p. 231-238.
37.
Willars, GB,
Nahorski SR,
and
Challiss RA.
Differential regulation of muscarinic acetylcholine receptor-sensitive polyphosphoinositide pools and consequences for signaling in human neuroblastoma cells.
J Biol Chem
273:
5037-5046,
1998.
38.
Wilson, AN,
and
Broadley KJ.
Analysis of the direct and indirect effects of adenosine on atrial and ventricular cardiac muscle.
Can J Physiol Pharmacol
67:
294-303,
1989.
39.
Xie, LH,
Takano M,
Kakei M,
Okamura M,
and
Noma A.
Wortmannin, an inhibitor of phosphatidylinositol kinases, blocks the MgATP-dependent recovery of Kir6.2/SUR2A channels.
J Physiol (Lond)
514:
655-665,
1999.
40.
Xie, LH,
Horie M,
and
Takano M.
Phospholipase C-linked receptors regulate the ATP-sensitive potassium channel by means of phosphatidylinositol 4,5-bisphosphate metabolism.
Proc Natl Acad Sci USA
96:
15292-15297,
1999.
41.
Yokoshiki, H,
Sunagawa M,
Seki T,
and
Sperelakis N.
ATP-sensitive K+ channels in pancreatic, cardiac, and vascular smooth muscle cells.
Am J Physiol Cell Physiol
274:
C25-C37,
1998.
Am J Physiol Heart Circ Physiol 282(2):H757-H765
0363-6135/02 $5.00
Copyright © 2002 the American Physiological Society